SI
ABBV icon

Sava Infond’s AbbVie ABBV Stock Holding History

Sava Infond’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46M Buy
21,692
+10,846
+100% +$2.33M 0.39% 53
2026
Q1 		$2.36M Sell
10,846
-70
-0.6% -$15.5K 0.33% 69
2025
Q4 		$2.49M Sell
10,916
-700
-6% -$159K 0.34% 60
2025
Q3 		$2.69M Sell
11,616
-100
-0.9% -$20.4K 0.38% 53
2025
Q2 		$2.17M Buy
11,716
+1,200
+11% +$223K 0.34% 57
2025
Q1 		$2.2M Sell
10,516
-100
-0.9% -$19.4K 0.42% 50
2024
Q4 		$1.89M Buy
+10,616
New +$1.95M 0.33% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sava Infond's ABBV Position: Q2 2026 in Review

Sava Infond increased its AbbVie (ABBV) stake by 100% in Q2 2026, buying an estimated $2.33M and bringing the position to 21,692 shares worth $5.46M. The position accounts for 0.39% of the portfolio, ranked #53.

Sava Infond first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sava Infond held 21,692 shares of AbbVie worth $5.46M as of Q2 2026.
  • Sava Infond bought 10,846 AbbVie shares in Q2 2026, an estimated $2.33M.
  • AbbVie made up 0.39% of Sava Infond's portfolio in Q2 2026, its #53 holding.
  • Sava Infond first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.